NEW COLLECTION!

Lilia is proud to offer her new eyegaze art and jewelry to commemorate the first FDA approved drug for Rett Syndrome. This event is especially meaningful to Lilia because she was participant 003 at the Chicago Rush Children's Hospital trials for Trofinetide (Daybue).

4 products

4 products